FDA Adverse Event Injury Summary report: N

REMUNITY PUMP

MDR report key: 16313025 · Received February 6, 2023

Report

Report Number
MW5114747
Event Type
Injury
Date Received
February 6, 2023
Report Date
February 2, 2023
Manufacturer
DEKA RESEARCH AND DEVELOPMENT
Product Code
QJY
Adverse Event
Yes
Report Source
Voluntary report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

PATIENT REPORTED THAT ABOUT A WEEK AGO SHE STARTED TO EXPERIENCE SEVERE HEADACHES. PER MD REQUEST, SHE WENT TO THE HOSPITAL ON (B)(6) 2022 FOR TESTING DUE TO THE PAIN AND WENT HOME THE NEXT DAY. PATIENT IS CURRENTLY TITRATING ON RERNODULIN VIA REMUNITY PUMP SELF MIX WHICH COULD BE CAUSING THE HEADACHES. PATIENT HAS BEEN TAKING EXCEDRIN MIGRAINE TO HELP ALLEVIATE THE PAIN. MD IS AWARE. NO OTHER INFORMATION PROVIDED AT THIS TIME. REPORTED TO (B)(6) BY PT/CAREGIVER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2312601 REMUNITY PUMP INFUSION PUMP, DRUG-SPECIFIC, PHARMACY-FILLED QJY DEKA RESEARCH AND DEVELOPMENT

Patients

Seq Age Sex Outcome Treatment
1 Female Hospitalization AMBRISENTAN| REMODULIN